Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Universitätsklinik für Innere Medizin

Klinische Abteilung für Onkologie

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Originalarbeit (Zeitschrift)

** Alkan, HF; Vesely, PW; Hackl, H; Foßelteder, J; Schmidt, DR; Vander Heiden, MG; Pichler, M; Hoefler, G; Bogner-Strauss, JG Deficiency of malate-aspartate shuttle component SLC25A12 induces pulmonary metastasis.
Cancer Metab. 2020; 8(1):26-26 Doi: 10.1186/s40170-020-00232-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M; Gerger, A; Pichler, M External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Cancer Med. 2020; 9(15):5473-5479 Doi: 10.1002/cam4.3233 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Bianconi, D; Herac, M; Posch, F; Schmeidl, M; Unseld, M; Kieler, M; Brettner, R; Mullauer, L; Riedl, J; Gerger, A; Scheithauer, W; Prager, G Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
THER ADV MED ONCOL. 2020; 12: 1758835920928635 Doi: 10.1177/1758835920928635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Bjelic-Radisic, V; Fitzal, F; Knauer, M; Steger, G; Egle, D; Greil, R; Schrenk, P; Balic, M; Singer, C; Exner, R; Soelkner, L; Gnant, M; ABCSG Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.
BMC Cancer. 2020; 20(1): 392-392. Doi: 10.1186/s12885-020-06894-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Brčić, I; Brodowicz, T; Cerroni, L; Kashofer, K; Serbanescu, GL; Kasseroler, MT; Amann, G; Scheipl, S; Szkandera, J; Leithner, A; Liegl-Atzwanger, B Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum.
Pathology. 2020; 52(2):236-242 Doi: 10.1016/j.pathol.2019.09.015 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M; Austrian Breast and Colorectal Cancer Study Group The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer. 2020; 134:99-106 Doi: 10.1016/j.ejca.2020.04.020 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Fesl, C; Sölkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stöger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Eur J Cancer. 2020; 127(4):12-20 Doi: 10.1016/j.ejca.2019.11.024
Web of Science PubMed FullText FullText_MUG

 

** Fischer, S; Tandstad, T; Cohn-Cedermark, G; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, M; Langberg, CW; Ståhl, O; Fankhauser, CD; Hamid, AA; Koutsoukos, K; Shamash, J; White, J; Bokemeyer, C; Beyer, J; Gillessen, S, , Global, Germ-Cell, Cancer, Group Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2020; 38(12):1322-1331 Doi: 10.1200/JCO.19.01876 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gilg, MM; Sunitsch, S; Leitner, L; Bergovec, M; Szkandera, J; Leithner, A; Liegl-Atzwanger, B Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Orthop Traumatol Surg Res. 2020; 106(6): 1059-1065. Doi: 10.1016/j.otsr.2020.04.017
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283 Doi: 10.1002/hon.2727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hochmair, MJ; Fabikan, H; Illini, O; Weinlinger, C; Setinek, U; Krenbek, D; Prosch, H; Rauter, M; Schumacher, M; Wöll, E; Wass, R; Brehm, E; Absenger, G; Bundalo, T; Errhalt, P; Urban, M; Valipour, A Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.
PHARMACEUTICALS-BASE. 2020; 13(11): Doi: 10.3390/ph13110371 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082247 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Jahn, SW; Bösl, A; Tsybrovskyy, O; Gruber-Rossipal, C; Helfgott, R; Fitzal, F; Knauer, M; Balic, M; Jasarevic, Z; Offner, F; Moinfar, F Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests.
Br J Cancer. 2020; 122(12):1744-1746 Doi: 10.1038/s41416-020-0838-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Jahn-Kuch, D; Domke, A; Bitsche, S; Stöger, H; Avian, A; Jeitler, K; Posch, N; Siebenhofer, A End-of-life decision making by Austrian physicians - a cross-sectional study.
BMC Palliat Care. 2020; 19(1): 4-4. Doi: 10.1186/s12904-019-0509-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Jayavelu, AK; Schnöder, TM; Perner, F; Herzog, C; Meiler, A; Krishnamoorthy, G; Huber, N; Mohr, J; Edelmann-Stephan, B; Austin, R; Brandt, S; Palandri, F; Schröder, N; Isermann, B; Edlich, F; Sinha, AU; Ungelenk, M; Hübner, CA; Zeiser, R; Rahmig, S; Waskow, C; Coldham, I; Ernst, T; Hochhaus, A; Jilg, S; Jost, PJ; Mullally, A; Bullinger, L; Mertens, PR; Lane, SW; Mann, M; Heidel, FH Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Nature. 2020; 588(7836):157-163 Doi: 10.1038/s41586-020-2968-3
Web of Science PubMed FullText FullText_MUG

 

** Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stöger, H; Stotz, M; Gerger, A; Pichler, M Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Cancers (Basel). 2020; 12(5): Doi: 10.3390/cancers12051154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Knittelfelder, O; Delago, D; Jakse, G; Lukasiak, K; Thurner, EM; Thurnher, D; Pichler, M; Renner, W; Stranzl-Lawatsch, H; Langsenlehner, T The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy.
Cancers (Basel). 2020; 12(3): 626 Doi: 10.3390/cancers12030626 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lackner, A; Tiefenthaler, V; Mirzayeva, J; Posch, F; Rossmann, C; Kastrati, K; Radner, H; Demel, U; Gretler, J; Stotz, M; Graninger, WB; Stradner, MH The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study.
Ther Adv Musculoskelet Dis. 2020; 12: 1759720X20975907-1759720X20975907. Doi: 10.1177/1759720X20975907 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Leitner, L; Posch, F; Amerstorfer, F; Sadoghi, P; Leithner, A; Glehr, M The Dark Side of Arthroplasty: Competing Risk Analysis of Failed Hip and Knee Arthroplasty With Periprosthetic Joint Infection.
J Arthroplasty. 2020; 35(9):2601-2606 Doi: 10.1016/j.arth.2020.04.078 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Porubsky, C; Pichler, M; Brcic, L; Anegg, U; Balic, M; Dandachi, N; Maier, A; Smolle, M; Smolle, J; Smolle-Juettner, FM Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082066 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Maier, A; Kovacs, G; Balic, M; Smolle, J; Smolle-Juettner, FM Preoperative Peak Oxygen Consumption: A Predictor of Survival in Resected Lung Cancer.
Cancers (Basel). 2020; 12(4): Doi: 10.3390/cancers12040836 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lindenmann, J; Fink-Neuboeck, N; Taucher, V; Pichler, M; Posch, F; Brcic, L; Smolle, E; Koter, S; Smolle, J; Smolle-Juettner, FM Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic Score.
Cancers (Basel). 2020; 12(1): Doi: 10.3390/cancers12010152 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lu, C; Terbuch, A; Dolling, D; Yu, J; Wang, H; Chen, Y; Fountain, J; Bertan, C; Sharp, A; Carreira, S; Isaacs, WB; Antonarakis, ES; De Bono, JS; Luo, J Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype.
Ann Oncol. 2020; 31(9):1178-1185 Doi: 10.1016/j.annonc.2020.04.473
Web of Science PubMed FullText FullText_MUG

 

** Merola, E; Rinke, A; Partelli, S; Gress, TM; Andreasi, V; Kollár, A; Perren, A; Christ, E; Panzuto, F; Pascher, A; Jann, H; Arsenic, R; Cremer, B; Kaemmerer, D; Kump, P; Lipp, RW; Agaimy, A; Wiedenmann, B; Falconi, M; Pavel, ME Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Ann Surg Oncol. 2020; 27(5):1348-1355 Doi: 10.1245/s10434-019-08049-5
Web of Science PubMed FullText FullText_MUG

 

** Mir, Seyed, Nazari, P; Berghoff, AS; Preusser, M; Moik, F; Posch, F; Ricken, G; Riedl, J; Hell, L; Marosi, C; Hainfellner, JA; Pabinger, I; Ay, C Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma.
ESMO Open. 2020; 5(3):e000647 Doi: 10.1136/esmoopen-2019-000647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mirzaei, S; Lipp, RW Peptide and pseudo-peptide.
Q J Nucl Med Mol Imaging. 2020; 64(4):364-370 Doi: 10.23736/S1824-4785.20.03311-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moik, F; Posch, F; Grilz, E; Scheithauer, W; Pabinger, I; Prager, G; Ay, C Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.
Thromb Res. 2020; 187:9-17 Doi: 10.1016/j.thromres.2020.01.002 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Posch, F; Zielinski, C; Pabinger, I; Ay, C Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials.
Res Pract Thromb Haemost. 2020; 4(4):550-561 Doi: 10.1002/rth2.12359 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; van, Es, N; Posch, F; Di, Nisio, M; Fuereder, T; Preusser, M; Pabinger, I; Ay, C Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study.
Cancers (Basel). 2020; 12(9): Doi: 10.3390/cancers12092493 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Zöchbauer-Müller, S; Posch, F; Pabinger, I; Ay, C Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer.
Cancers (Basel). 2020; 12(6): Doi: 10.3390/cancers12061619 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moritz, J; Bauernhofer, T; Mannweiler, S; Langsenlehner, T; Pummer, K; Dandachi, N; Pichler, M Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients.
In Vivo. 2020; 34(6): 3631-3638. Doi: 10.21873/invivo.12209 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, SO; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Heitzer, E; Geigl, JB; Bauernhofer, T; Speicher, MR On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
NPJ Precis Oncol. 2020; 4(1):30 Doi: 10.1038/s41698-020-00134-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G; Schuuring, E; Groen, HJM; Geigl, JB; Heitzer, E; Speicher, MR Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.
ESMO Open. 2020; 5(5):e000872 Doi: 10.1136/esmoopen-2020-000872 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Rodriguez-Aguayo, C; Nam, SY; Dragomir, MP; Bayraktar, R; Anfossi, S; Knutsen, E; Ivan, C; Fuentes-Mattei, E; Lee, SK; Ling, H; Catela Ivkovic, T; Huang, G; Huang, L; Okugawa, Y; Katayama, H; Taguchi, A; Bayraktar, E; Bhattacharya, R; Amero, P; He, WR; Tran, AM; Vychytilova-Faltejskova, P; Klec, C; Bonilla, DL; Zhang, X; Kapitanovic, S; Loncar, B; Gafà, R; Wang, Z; Cristini, V; Hanash, SM; Bar-Eli, M; Lanza, G; Slaby, O; Goel, A; Rigoutsos, I; Lopez-Berestein, G; Calin, GA Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.
Gut. 2020; 69(10): 1818-1831. Doi: 10.1136/gutjnl-2019-318903 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Popper, HH; Gruber-Mosenbacher, U; Pall, G; Mullauer, L; Hochmair, M; Krenbek, D; Brcic, L; Schmitz, K; Lamprecht, B; Eckmayr, J; Hilbe, W; Hutarew, G; Errhalt, P; Kolb, R; Pirker, R; Setinek, U; Webersinke, G; Absenger, G; Hernler, T; Rauter, M; Wasicky, R The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers.
MEMO-MAG EUR MED ONC. 2020; Doi: 10.1007/s12254-019-00565-0
Web of Science FullText FullText_MUG

 

** Posch, F; Hofer, S; Thaler, J; Hell, L; Königsbrügge, O; Grilz, E; Mauracher, LM; Gebhart, J; Marosi, C; Jilma, B; Pabinger, I; Ay, C Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.
Transl Res. 2020; 215: 41-56. Doi: 10.1016/j.trsl.2019.08.009 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Riedl, J; Reitter, EM; Crowther, MJ; Grilz, E; Quehenberger, P; Jilma, B; Pabinger, I; Ay, C Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study.
J Thromb Haemost. 2020; 30 Suppl 4: Doi: 10.1111/jth.14774 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Prager, G; Gerger, A; Hofler, G; Webersinke, G; Rumpold, H; Winder, T; Bartsch, R; Preusser, M; Eisterer, W Position statement of the Austrian Society for Hematology and Medical Oncology on the use of molecular diagnostics in solid tumors.
MEMO-MAG EUR MED ONC. 2020; Doi: 10.1007/s12254-020-00662-5
Web of Science FullText FullText_MUG

 

** Reicher, A; Harris, AL; Prinz, F; Kiesslich, T; Wei, M; Öllinger, R; Rad, R; Pichler, M; Kwong, LN Generation of An Endogenous FGFR2-BICC1 Gene Fusion/58 Megabase Inversion Using Single-Plasmid CRISPR/Cas9 Editing in Biliary Cells.
Int J Mol Sci. 2020; 21(7): 2460 Doi: 10.3390/ijms21072460 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reisinger, AC; Schuller, M; Holzer, M; Stadler, JT; Hackl, G; Posch, F; Marsche, G; Sourij, H; Ekart, R; Eller, K; Eller, P Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock-A Prospective Pilot Study.
Front Med (Lausanne). 2020; 7:579677-579677 Doi: 10.3389/fmed.2020.579677 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082319 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Posch, F; Prager, G; Eisterer, W; Oehler, L; Sliwa, T; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Neumann, HJ; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Laengle, F; Wöll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
Ther Adv Med Oncol. 2020; 12: 1758835919900872-1758835919900872. Doi: 10.1177/1758835919900872 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Safi, S; Yamauchi, Y; Hoffmann, H; Weichert, W; Jost, PJ; Winter, H; Muley, T; Beckhove, P Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer.
Cancers (Basel). 2020; 12(12): Doi: 10.3390/cancers12123496 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Foßelteder, J; Svoboda, M; Resel, M; Barth, DA; Pichler, R; Bauernhofer, T; Zigeuner, RE; Pummer, K; Slaby, O; Klec, C; Pichler, M Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer.
Cancers (Basel). 2020; 12(5): 1200 Doi: 10.3390/cancers12051200 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Sestak, I; Filipits, M; Buus, R; Rudas, M; Balic, M; Knauer, M; Kronenwett, R; Fitzal, F; Cuzick, J; Gnant, M; Greil, R; Dowsett, M; Dubsky, P Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer.
Clin Cancer Res. 2020; 26(17): 4682-4687. Doi: 10.1158/1078-0432.CCR-20-0260
Web of Science PubMed FullText FullText_MUG

 

** Singer, CF; Pfeiler, G; Hubalek, M; Bartsch, R; Stöger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Maria Tea, MK; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M; Austrian Breast & Colorectal Cancer Study Group Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Eur J Cancer. 2020; 132:43-52 Doi: 10.1016/j.ejca.2020.03.018
Web of Science PubMed FullText FullText_MUG

 

** Smith, CG; Moser, T; Mouliere, F; Field-Rayner, J; Eldridge, M; Riediger, AL; Chandrananda, D; Heider, K; Wan, JCM; Warren, AY; Morris, J; Hudecova, I; Cooper, WN; Mitchell, TJ; Gale, D; Ruiz-Valdepenas, A; Klatte, T; Ursprung, S; Sala, E; Riddick, ACP; Aho, TF; Armitage, JN; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Welsh, SJ; Matakidou, A; Eisen, T; Massie, CE; Rosenfeld, N; Heitzer, E; Stewart, GD Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Genome Med. 2020; 12(1): 23-23. Doi: 10.1186/s13073-020-00723-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Sande, MV; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; van Praag, V; Fiocco, M; Panotopoulos, J; Willegger, M; Windhager, R; Dijkstra, SPD; van Houdt, WJ; Riedl, JM; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Smolle, J; Andreou, D; Leithner, A; Gronchi, A; Haas, RL; Szkandera, J Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.
Cancers (Basel). 2019; 12(1): Doi: 10.3390/cancers12010047 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Schaffler, A; Leithner, A; Van, Praag, VM; Bergovec, M; Szkandera, J; Liegl-Atzwanger, B; Niethard, M; Tunn, PU; Van, De, Sande, M; Andreou, D Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre study.
J Surg Oncol. 2020; 121(4):605-611 Doi: 10.1002/jso.25856 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stelzl, A; Aziz, F; Riedl, JM; Posch, F; Smolle, MA; Stojakovic, T; Terbuch, A; Pichler, M; Bergovec, M; Leithner, A; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Sourij, H; Szkandera, J Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients.
Sci Rep. 2020; 10(1): 12438-12438. Doi: 10.1038/s41598-020-69237-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stotz, M; Barth, DA; Riedl, JM; Asamer, E; Klocker, EV; Kornprat, P; Hutterer, GC; Prinz, F; Lackner, K; Stöger, H; Gerger, A; Pichler, M The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Terbuch, A; Tiu, C; Candilejo, IM; Scaranti, M; Curcean, A; Bar, D; Estevez Timon, M; Ameratunga, M; Ang, JE; Ratoff, J; Minchom, AR; Banerji, U; de Bono, JS; Tunariu, N; Lopez, JS Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials.
Clin Cancer Res. 2020; 26(18):4805-4813 Doi: 10.1158/1078-0432.CCR-20-0454
Web of Science PubMed FullText FullText_MUG

 

** van Manen, L; Groen, JV; Putter, H; Pichler, M; Vahrmeijer, AL; Bonsing, BA; Mieog, JSD Stage-Specific Value of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Serum Levels on Survival and Recurrence in Pancreatic Cancer: A Single Center Study and Meta-Analysis.
Cancers (Basel). 2020; 12(10): 2970 Doi: 10.3390/cancers12102970 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zhou, Q; Perakis, SO; Ulz, P; Mohan, S; Riedl, JM; Talakic, E; Lax, S; Tötsch, M; Hoefler, G; Bauernhofer, T; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Genome Med. 2020; 12(1):20 Doi: 10.1186/s13073-020-0719-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833 Doi: 10.1007/s12253-020-00864-6
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Balic, M Treatment options in early triple-negative breast cancer Update from the San Antonio Breast Cancer Symposium 2019.
MEMO-MAG EUR MED ONC. 2020; Doi: 10.1007/s12254-020-00609-w [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Übersichtsarbeit

** Barth, DA; Drula, R; Ott, L; Fabris, L; Slaby, O; Calin, GA; Pichler, M Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.
Front Cell Dev Biol. 2020; 8:828 Doi: 10.3389/fcell.2020.00828 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Juracek, J; Slaby, O; Pichler, M; Calin, GA lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.
Cancers (Basel). 2020; 12(8): Doi: 10.3390/cancers12082148 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Prinz, F; Teppan, J; Jonas, K; Klec, C; Pichler, M Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer.
Noncoding RNA. 2020; 6(3): Doi: 10.3390/ncrna6030027 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Bekric, D; Neureiter, D; Ritter, M; Jakab, M; Gaisberger, M; Pichler, M; Kiesslich, T; Mayr, C Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.
J Clin Med. 2020; 9(4): 1200 Doi: 10.3390/jcm9041200 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Brausi, M; Hoskin, P; Andritsch, E; Banks, I; Beishon, M; Boyle, H; Colecchia, M; Delgado-Bolton, R; Höckel, M; Leonard, K; Lövey, J; Maroto, P; Mastris, K; Medeiros, R; Naredi, P; Oyen, R; de Reijke, T; Selby, P; Saarto, T; Valdagni, R; Costa, A; Poortmans, P ECCO Essential Requirements for Quality Cancer Care: Prostate cancer.
Crit Rev Oncol Hematol. 2020; 148: 102861-102861. Doi: 10.1016/j.critrevonc.2019.102861
Web of Science PubMed FullText FullText_MUG

 

** Henzinger, H; Barth, DA; Klec, C; Pichler, M Non-Coding RNAs and SARS-Related Coronaviruses.
Viruses. 2020; 12(12): Doi: 10.3390/v12121374 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hsieh, PL; Liao, YW; Pichler, M; Yu, CC MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells.
Cancers (Basel). 2020; 12(2): 340 Doi: 10.3390/cancers12020340 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Jonas, K; Calin, GA; Pichler, M RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer.
Int J Mol Sci. 2020; 21(8): Doi: 10.3390/ijms21082969 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klocker, EV; Suppan, C Biomarkers in Her2-Positive Disease.
BREAST CARE. 2020; 15(6): 586-593. Doi: 10.1159/000512283
Web of Science FullText FullText_MUG

 

** Regouc, M; Belge, G; Lorch, A; Dieckmann, KP; Pichler, M Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.
Cancers (Basel). 2020; 12(3): 749 Doi: 10.3390/cancers12030749 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Szkandera, J; Andreou, D; Palmerini, E; Bergovec, M; Leithner, A Treatment options in unresectable soft tissue and bone sarcoma of the extremities and pelvis - a systematic literature review.
EFORT Open Rev. 2020; 5(11):799-814 Doi: 10.1302/2058-5241.5.200069 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Teppan, J; Barth, DA; Prinz, F; Jonas, K; Pichler, M; Klec, C Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis.
Noncoding RNA. 2020; 6(4): Doi: 10.3390/ncrna6040042 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Balic, M Understanding and Treating HER Better.
Breast Care (Basel). 2020; 15(6):557-559 Doi: 10.1159/000512415 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Gerger, A Molecular profiling-ready for clinical routine.
MEMO-MAG EUR MED ONC. 2020; 13(4): 365-366. Doi: 10.1007/s12254-020-00663-4 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Lipp, RW Guest editorial.
AUST J CLIN ENDOCR M. 2020; 13(2): 43-43. Doi: 10.1007/s41969-020-00104-x [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Suppan, C; Balic, M It is time to prepare for D-CARE!
ANN TRANSL MED. 2020; 8(21): 1339 Doi: 10.21037/atm-2020-99 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fallbericht

** Lembeck, AL; Puchas, P; Hutterer, G; Barth, DA; Terbuch, A; Bauernhofer, T; Pichler, M MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Noncoding RNA. 2020; 6(1): Doi: 10.3390/ncrna6010002 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Korrektur

** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2020; 11(1): 1965-1965. Doi: 10.1038/s41467-020-15799-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Andritsch, E; Farkas, C; Stanzer, S; Bauernhofer, T; Vigier, M Psychoneuroimmunological predictors of breast cancer progression.
J PSYCHOSOM RES. 2020; 133: 110081- Doi: 10.1016/j.jpsychores.2020.110081
Web of Science FullText FullText_MUG

 

** Bauernhofer, T; Stanzer, S; Prietl, B; Kofler, S; Obermayer-Pietsch, B; Pichler, M; Sourij, H; Pieber, T Tregs cells - a double edged sword? Lessons learned from colorectal cancer in comparison to type 1 diabetes mellitus.
ONCOL RES TREAT. 2020; 43(SUPPL 4):127-128. [Poster]
Web of Science

 

** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakic, E; Richtig, G; Richtig, E; Rohrer, P; Koch, L; Wolf, I; Koch, C; Rainer, B; Koeller, M; Pichler, M; Kashofer, K; Aigelsreiter, A Feasibility and first results of circulating tumor DNA as a marker for treatment response in metastatic melanoma patients using Next Generation Sequencing.
ONCOL RES TREAT. 2020; 43(SUPPL 4):166-167. [Onlinepräsentation]
Web of Science

 

** Gampenrieder, SP; Rinnerthaler, G; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R Landscape of HER2-low metastatic breast cancer (MBC): Results from the AGMT-MBC-Registry.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS19-P3-08-29 [Poster]
Web of Science FullText FullText_MUG

 

** Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Akhoundova, D; Maas, C; Uhlig, J; Fenchel, K; Greil, R; von der Heyde, E; Agocs, R; Weide, R; Modest, DP; Fritsch, R Retrospective analysis of treatment pathways in patients with BRAF(V600E)-mutant metastatic colorectal carcinoma - MORSECRC.
ONCOL RES TREAT. Abstractband für die Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 2020; 43(SUPPL 4):131-131.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 9-11, 2020; Basel, SWITZERLAND. [Onlinepräsentation]
Web of Science

 

** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Illini, O; Hochmair, MJ; Fabikan, H; Weinlinger, C; Setinek, U; Krenbek, D; Prosch, H; Rauter, M; Schumacher, M; Woll, E; Wass, R; Brehm, E; Absenger, G; Bundalo, T; Errhalt, P; Urban, M; Valipour, A Later-line treatment with lorlatinib in ALK-and ROS1-rearrangement-positive NSCLC: a retrospective, multicenter analysis.
WIEN KLIN WOCHENSCHR. 2020; 132(19-20):610-610. [Poster]
Web of Science

 

** Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoger, H; Pichler, M Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS19-P1-05-13 [Poster]
Web of Science FullText FullText_MUG

 

** Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.202 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** König, E; Pux, C; Schippinger, W; Stoiser, E; Krause, R; Zollner-Schwetz, I Increasing influenza vaccination rates among health care workers and residents of long-term care facilities for the elderly in Graz, Austria.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):79-79.-Österreichische Gesellschaft für Innere Medizin ; Sept 24-26, 2020; Salzburg, Austria. [Poster]
Web of Science

 

** Laprovitera, N; Porcellini, E; Riefolo, M; Broseghini, E; Garajova, I; Sabbioni, S; Pichler, M; Ardizzoni, A; D'Errico, A; Ferracin, M Cancer of unknown primary site-of-origin: An enigma ready to be miR-solved
CANCER RES. Abstracts. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; Virtuell. Doi: 10.1158/1538-7445.AM2020-5432 [Poster]
Web of Science FullText FullText_MUG

 

** Lichtenegger, K; Kopanz, J; Libiseller, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Beck, P; Holl, B; Pieber, T; De Campo, A DIGITAL DECISION SUPPORT FOR BASAL INSULIN THERAPY: RCT CONFIRMED READINESS FOR IMPLEMENTATION IN ACUTE-GERIATRIC CARE PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A110-A111.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-22, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16): Doi: 10.1158/1538-7445.AM2020-4295 [Poster]
Web of Science FullText FullText_MUG

 

** Perakis, SO; Weber, S; Graf, R; Zhou, Q; Riedl, JM; Dandachi, N; Balic, M; Gerger, A; Schuuring, E; Groen, HJ; Geigl, JB; Speicher, MR; Heitzer, E Identification of actionable targets in advanced cancer patients from circulating tumor DNA using clinical decision support platforms
CANCER RES. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; ELECTR NETWORK. Doi: 10.1158/1538-7445.AM2020-1315 [Poster]
Web of Science FullText FullText_MUG

 

** Posch, F; Barth, D; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Riedl, JM C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study.
ANN ONCOL. 2020; 31: S286-S286.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.234 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

** Riedl, J; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Schaberl-Moser, R; Stotz, M; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: An Austrian observational Tri-Center comparative effectiveness analysis.
ONCOL RES TREAT. 2020; 43(SUPPL 4):215-215. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Gantschnigg, A; Horvath, L; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A FOLFIRINOX versus Gemcitabine/nabPaclitaxel as First-line palliative Therapy in advanced Pancreatic Cancer: a Propensity-Score Analysis.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):78-79.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Stoger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
ANN ONCOL. 2020; 31: S942-S942.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2013 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R Prognosis of triple negative metastatic breast cancer (MBC): Results from the AGMT_MBC-Registry.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS19-P5-06-29 [Poster]
Web of Science FullText FullText_MUG

 

** Schwarzenbacher, E; Moik, F; Horvath, L; Renneberg, F; Posch, F; Barth, D; Gantschnigg, A; Schaberl-Moser, R; Pichler, M; Stotz, M; Stoger, H; Ay, C; Greil, R; Gerger, A; Djanani, A; Schlick, K; Riedl, J Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX.
ONCOL RES TREAT. 2020; 43(SUPPL 4):214-214. [Poster]
Web of Science

 

** Schwarzenbacher, E; Moik, F; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Barth, D; Stotz, M; Schaberl-Moser, R; Pichler, M; Ay, C; Stoger, H; Greil, R; Djanani, A; Gerger, A; Schlick, K; Riedl, JM Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX.
ANN ONCOL. 2020; 31: S949-S950.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.2035 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Singer, CF; Egle, D; Greil, R; Ohler, L; Petru, E; Suppan, C; Marhold, M; Pfeiler, G; Brunner, C; Tinchon, C; Halper, S; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Hennebelle, M; Mraz, B; Bartsch, R REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC).
ANN ONCOL. 2020; 31: S77-S78.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.272 [Oral Communication] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, VE; Posch, F; Henzinger, EC; Stoeger, H; Dandachi, N; Balic, M Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
J CLIN ONCOL. 2020; 38(15): [Onlinepräsentation]
Web of Science FullText

 

** Suppan, C; Zhou, Q; Graf, R; Klocker, V; Terbuch, A; Dandachi, N; Heitzer, E; Balic, M Liquid biopsy-based detection of PIK3Ca mutations in HR positive metastastic breast cancer patients.
ANN ONCOL. 2020; 31: S41-S41.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.213 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Szkandera, J The value of adoptive cell therapy and immunotherapy.
ONCOL RES TREAT. 2020; 43(SUPPL 4):10-10.-DGHO; OKT 09-12, 2021; Virtuell. [Oral Communication]
Web of Science

 

** Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N Massive cardiac AL amyloidosis in the absence of monoclonal gammopathy.
WIEN KLIN WOCHENSCHR. 2020; 132: S237-S237. [Poster]
Web of Science FullText

 

** Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N The exceptional Case of massive cardiac AL-Amyloidosis with missing monoclonal Gammopathy.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):73-73.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Kommentar

** Bago-Horvath, Z; Rudas, M; Singer, CF; Greil, R; Balic, M; Lax, SF; Kwasny, W; Hulla, W; Gnant, M; Filipits, M Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5.
Clin Cancer Res. 2020; 26(21): 5682-5688. Doi: 10.1158/1078-0432.CCR-20-0673
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Hatzl, S; Ay, C Heparins as cancer therapy: in theory, they should have worked.
Lancet Haematol. 2020; 7(10): e703-e704-e703-e704. Doi: 10.1016/S2352-3026(20)30276-3
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum